Qube Research & Technologies LTD Agenus Inc Transaction History

Qube Research & Technologies LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.63 - $1.14 $2.49 Million - $4.51 Million	3,959,068 New	3,959,068 $3.29 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $1.03 Million - $1.6 Million	784,457 Added 69.87%	1,907,247 $3.05 Million
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $1.4 Million - $2.84 Million	962,787 Added 601.73%	1,122,790 $1.71 Million
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $1.1 Million - $1.76 Million	-542,951 Reduced 77.24%	160,003 $384,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $1.38 Million - $2.21 Million	702,954 New	702,954 $1.44 Million
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $516,636 - $1.05 Million	-397,413 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.35 - $3.47 $904,818 - $1.34 Million	385,029 Added 3109.08%	397,413 $978,000
Q4 2021 Feb 01, 2022	BUY	$2.92 - $5.74 $36,161 - $71,084	12,384 New	12,384 $40,000
Q2 2021 Aug 13, 2021	SELL	$2.56 - $5.49 $251,558 - $539,474	-98,265 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $237,352 - $463,233	88,235 Added 879.71%	98,265 $267,000
Q4 2020 Feb 16, 2021	BUY	$3.17 - $4.49 $31,795 - $45,034	10,030 New	10,030 $32,000
Q3 2020 Nov 12, 2020	SELL	$2.98 - $5.2 $99,529 - $173,674	-33,399 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.29 - $4.24 $76,483 - $141,611	33,399 New	33,399 $131,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.